Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “chronic myeloid leukemia”
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT03421626. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia
ClinicalTrials.gov study NCT00677859. IPD Sharing: Not stated. Countries: 2. Publications: 0.
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT03481868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
ClinicalTrials.gov study NCT03454503. IPD Sharing: NO. Countries: 1. Publications: 0.
ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
ClinicalTrials.gov study NCT06787144. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders
ClinicalTrials.gov study NCT02210858. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
ClinicalTrials.gov study NCT00461929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
ClinicalTrials.gov study NCT07375355. IPD Sharing: NO. Countries: 0. Publications: 0.
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT01751425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
ClinicalTrials.gov study NCT03045120. IPD Sharing: NO. Countries: 1. Publications: 0.
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
ClinicalTrials.gov study NCT00052520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms
ClinicalTrials.gov study NCT01650467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT07061145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04512105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
ClinicalTrials.gov study NCT05367700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
ClinicalTrials.gov study NCT01657604. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT05883956. IPD Sharing: NO. Countries: 2. Publications: 0.
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
ClinicalTrials.gov study NCT03516279. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00087204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03075969. IPD Sharing: Not stated. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.